Which statement best describes how information in the Investigator's Brochure should be presented?

Which statement best describes how information in the Investigator's Brochure should be presented?

• A. Concise, simple, objective, balanced, and non-promotional
• B. The process is promotional
• C. Long and unedited raw data
• D. Classified and not accessible to IRB

Answer: (A)

The essential idea is that the Investigator’s Brochure should be written to inform investigators and ethics committees in a clear, neutral way. It needs to present information concisely and simply, sticking to objective data and a balanced view of risks and benefits, without any marketing language. This neutral, non-promotional tone helps ensure that those reviewing and conducting the trial can accurately assess safety, dosing, pharmacology, and the overall risk–benefit profile. A promotional tone would undermine trial integrity and regulatory oversight, which is why that option isn’t appropriate. Presenting long, unedited raw data isn’t practical for an IB, which is meant to summarize and highlight the most relevant information in a usable form, with references to the full data as needed. Keeping information accessible to IRBs and investigators is also essential; withholding or classifying the document would prevent proper ethical and regulatory review.

The essential idea is that the Investigator’s Brochure should be written to inform investigators and ethics committees in a clear, neutral way. It needs to present information concisely and simply, sticking to objective data and a balanced view of risks and benefits, without any marketing language. This neutral, non-promotional tone helps ensure that those reviewing and conducting the trial can accurately assess safety, dosing, pharmacology, and the overall risk–benefit profile.

A promotional tone would undermine trial integrity and regulatory oversight, which is why that option isn’t appropriate. Presenting long, unedited raw data isn’t practical for an IB, which is meant to summarize and highlight the most relevant information in a usable form, with references to the full data as needed. Keeping information accessible to IRBs and investigators is also essential; withholding or classifying the document would prevent proper ethical and regulatory review.